MELD and MELD XI Scores as Predictors of Mortality After Pericardiectomy for Constrictive Pericarditis

Juan C Diaz Soto1, William J Mauermann1, Brian D Lahr2

  • 1Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Rochester, MN.

Abstract

Insights

The Model for End-Stage Liver Disease-XI (MELD-XI) and MELD scores effectively predict mortality and morbidity after pericardiectomy for constrictive pericarditis. These scores offer a reliable method for stratifying patient risk before surgery.

Area of Science:

  • Cardiovascular Surgery
  • Hepatology
  • Nephrology

Background:

  • Constrictive pericarditis necessitates surgical intervention via pericardiectomy.
  • Risk stratification is crucial for optimizing outcomes in patients undergoing major cardiac surgery.
  • The Model for End-Stage Liver Disease (MELD) and its variant MELD-XI are established predictors of mortality in various patient populations.

Purpose of the Study:

  • To evaluate the association between preoperative MELD and MELD-XI scores and postoperative outcomes in patients undergoing pericardiectomy.
  • To determine the predictive value of MELD and MELD-XI for mortality and morbidity following pericardiectomy for constrictive pericarditis.

Main Methods:

  • Retrospective analysis of 175-226 patients undergoing pericardiectomy for constrictive pericarditis (2007-2017).
  • MELD and MELD-XI scores were calculated within 30 days preoperatively.
  • Cox regression models assessed the association between scores and outcomes, adjusting for covariates. Primary outcome: 90-day mortality.

Main Results:

  • Higher MELD and MELD-XI scores were significantly associated with increased 90-day mortality (P<.001).
  • Both scores correlated with increased postoperative renal failure, need for transfusions, and chest tube output.
  • MELD-XI additionally predicted prolonged intubation and extended ICU/hospital stays.

Conclusions:

  • Preoperative MELD and MELD-XI scores are valuable tools for risk stratification in patients undergoing pericardiectomy.
  • MELD-XI demonstrated comparable or superior performance to MELD in predicting various adverse postoperative outcomes.
  • These scoring systems can aid in identifying high-risk patients for constrictive pericarditis surgery.

Related Concept Videos

Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
104
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
141
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
82
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
86
Mitral Valve Prolapse II: Assessment and Management01:22

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
159
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
146